EUVIMEDEUVIMED entdecken
Crossref

Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma

Vincent Harlay, Alexandre Bertucci, Céline Boucard, Gregorio Petrirena, Chantal Campello, Maryline Barrié, Didier Autran, Olivier Chinot, Emeline Tabouret

Anticancer Research · 2024

DOI: 10.21873/anticanres.17272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Vincent Harlay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Neuro-oncologie, Centre Hospitalier Universitaire Timone, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France; Vincent.…. Hauptthemen laut MEDLINE: Methotrexate, Central Nervous System Neoplasms, Lymphoma, Potassium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateCentral Nervous System NeoplasmsLymphomaPotassiumHumansFemaleMaleAgedMiddle AgedProspective StudiesAntimetabolites, AntineoplasticAdultAged, 80 and overAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

PCNSLPrimary central nervous system lymphomabiomarkerhigh-dose methotrexatetoxicity

Substanzen

MethotrexatePotassiumAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Service de Neuro-oncologie, Centre Hospitalier Universitaire Timone, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France; Vincent.harlay@ap-hm.fr.
  • Service de Neuro-oncologie, Centre Hospitalier Universitaire Timone, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Institut de Neurophysiopathologie, Aix-Marseille University, Centre National de la Recherche Scientifique (CNRS), Institut National des Sciences Appliquées or Institut National Polytechnique (INP), Marseille, France.
  • Plateforme PE"TRANSLA", Aix-Marseille University, Réseau Préclinique et Translationnel de Recherche en Neuro-oncologie, Marseille, France.

Zitieren

APA

Harlay, V., Bertucci, A., Boucard, C., Petrirena, G., Campello, C., Barrié, M., Autran, D., Chinot, O., & Tabouret, E. (2024). Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma. Anticancer Research. https://doi.org/10.21873/anticanres.17272

Vancouver

Harlay V, Bertucci A, Boucard C, Petrirena G, Campello C, Barrié M, et al. Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma. Anticancer Research. 2024. doi:10.21873/anticanres.17272

BibTeX
@article{Harlay2024,
  author = {Harlay, Vincent and Bertucci, Alexandre and Boucard, Céline and Petrirena, Gregorio and Campello, Chantal and Barrié, Maryline and Autran, Didier and Chinot, Olivier and Tabouret, Emeline},
  title = {Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17272}
}
Kostenlos starten →